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http://dx.doi.org/10.1016/j.kjms.201Abstract To investigate whether 4-methylcatechol (4MC) could decrease the duration of the
thermosensation disorder and promote the innervation of peptidergic intraepidermal nerve
fibers (IENFs), we developed a resiniferatoxin (RTX)-induced neuropathic mouse model with
thermal analgesia and skin denervation that was followed by daily 4MC treatment. On day 7 after
RTX administration (RTXd7), the substance P (SP)(þ) IENFs were completely depleted compared
with the vehicle group (p < 0.0001), whereas the calcitonin gene-related peptide (CGRP)(þ)
IENFswere dramatically, but not completely, depleted (p< 0.0001).While SP(þ) IENFs remained
depleted (pZ 0.0043), CGRP(þ) IENFs were recovered by RTXd84 (pZ 0.78). 4MC had no effect
on the reinnervation of SP(þ) IENFs, but markedly promoted the reinnervation of CGRP(þ) IENFs
on RTXd35 (pZ 0.035). On RTXd56, CGRP(þ) IENFs were comparable with the vehicle group
(pZ 0.39). In addition, 4MC normalized thermal analgesia on RTXd35 compared with RTX group
(pZ0.007). In the current study, the significant promotionof reinnervation ofCGRP(þ) IENFsandof Anatomy, School of Medicine, College of Medicine, Kaohsiung Medical University, 100, Shih-Chuan
tw (Y.-L. Hsieh).
hsiung Medical University. Published by Elsevier Taiwan LLC. All rights reserved.
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406 T.-H. Hsiao et al.thermal latencies on RTXd35 by 4MC indicated that CGRP(þ) IENFs were responsible for the
thermal transmission in chronic phase of RTX-induced neuropathy.
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Calcitonin gene-related peptide (CGRP) and substance P
(SP) are neurotransmitters that are used by peptidergic
small-diameter dorsal root ganglia (DRGs) neurons and are
presumably responsible for transmitting nociceptive stimuli
from intraepidermal nerve fibers (IENFs) in the skin. These
neurons also express transient receptor potential vanilloid
subtype 1 (TRPV1) [1,2], which can be depleted by an
ultrapotent capsaicin agonist, resiniferatoxin (RTX) [2e4].
RTX is widely used in pain studies to deplete the IENFs,
which leads to thermal analgesia [5e8]. Previous studies
focused on the depletion of TRPV1(þ) neurons and their
cutaneous terminal, which corresponds to the thermal
transmission [3,4]. Together with the development of
thermal analgesia by RTX, those observations raise the
following issues: what is the effect of RTX in the depletion
of SP(þ) and CGRP(þ) IENFs and are they in the same
degree? If there is a differential effect by RTX, which
phenotypic IENFs are susceptible and which profiles of
phenotypic IENFs parallel the recovery of thermal sensation
in the chronic phase of RTX-induced neuropathy?
4-Methylcatechol (4MC) has been considered as a potent
stimulator of endogenous nerve growth factor (NGF)
[9e11], which enhanced skin reinnervation [8,11]. In
clinics, patients with thermal analgesia are accompanied by
skin denervation. These observations implied that the IENFs
reinnervation could relieve thermosensation disorders. Our
previous study demonstrated that 4MC promoted the
synthesis of NGF [11] and skin reinnervation, particularly by
CGRP IENFs [8]. Taken together, these results suggest the
potential for a therapeutic strategy to improve the skin
reinnervation and to reverse the thermal analgesia. The
following issues were raised: (1) whether 4MC has the
differential effect in peptidergic IENFs, and (2) whether
4MC could promote specific phenotypic IENFs reinnervation
that reversed thermal analgesia?
To address these issues, we generated a RTX-induced
thermal analgesic mouse model and investigated the
depletion of SP(þ) and CGRP(þ) IENFs with footpad skin
sections. After the administration of 4MC, there were
significant increases in the densities of CGRP(þ) IENFs,
while there were reductions in the duration of thermal
analgesia, suggesting that CGRP(þ) IENFs are responsible
for the transmission of thermal nociception.
Materials and methods
RTX-induced neuropathy and 4MC treatment
Experiments were performed on 8-week-old adult male
imprinting control region mice (35e40 g). RTX (Sigma, St.
Louis, MO, USA) was dissolved in a vehicle (10% Tween-80and 10% ethanol in normal saline) [2,8]. The animals
received a single dose of RTX by intraperitoneal injection
(50 mg/kg, defined as the RTX group). One group received an
equal volume of vehicle to serve as the controls (the vehicle
group). 4MC (10 mg/kg; Wako, Osaka, Japan) was dissolved
in phosphate-buffered saline and was intraperitoneally
injected to mice on day 7 of RTX-induced neuropathy
(RTXd7). The group that received the 4MC injections was
defined as the 4MC group [11]. After treatment, mice were
housed in plastic cages on 12-hour light/12-hour dark cycle
and had access to water and food ad libitum. All procedures
were conducted in accordance with the ethical guidelines
for laboratory animals [12] and the protocol (Permit No.
100055) was approved by Kaohsiung Medical University,
Kaohsiung, Taiwan. All experimental procedures were per-
formed using 4% chloral hydrate (dose: 1 mL/100 g), and all
efforts were made to minimize suffering.
Evaluation of hot plate withdrawal latencies
Mice were placed on a 52 C hot plate (IITC, Woodland Hills,
CA, USA) enclosed in a Plexiglass cage. The withdrawal
latencies of the hind paw to thermal stimulations were
determined to an accuracy of 0.1 seconds. Each test session
consisted of three trials separated by 30-minute intervals.
The criteria of withdrawal included shaking, licking, or
jumping on the hot plate. Themean latencywas expressed as
the threshold of an individual animal to thermal stimulation.
Immunohistochemistry of footpad
Mice were killed by intracardiac perfusion with 0.1 M phos-
phate buffer (PB) followed by 4% paraformaldehyde (4P) in
0.1 M PB (pH Z 7.4) [13]. Footpad tissues were removed
after perfusion and postfixed in 4P overnight, followed by
cryoprotection with 30% sucrose. Tissues sections, 30-mm
thick, were cut on a sliding microtome. Briefly, the sections
were quenched with 1% H2O2 in methanol and blocked with
0.5% nonfat dry milk and 0.1% Triton X-100 in 0.5 M Tris
buffer (Tris). The tissue sections were incubated with
primary anti-SP (1:1000; DiaSorin, Stillwater, MN, USA) and
CGRP (1:1000; Sigma) antibodies overnight at 4 C, followed
by incubation with biotinylated secondary antibody for
another 1 hour. Then the avidinebiotin complex (Vector
Labs, Burlingame, CA, USA) method was used and the
activity of the reaction product was demonstrated with 3,30-
diaminobenzidine (Sigma). The sections were mounted on
gelatin-coated slides for quantification.
Quantification of SP(D) and CGRP(D) IENFs
SP(þ) and CGRP(þ) IENFs were counted under 400
magnification (Axiophot microscope; Zeiss, Oberkochen,
4MC promoted skin reinnervation 407Germany). The protocol for counting followed established
criteria in a coded fashion [14]. Fibers with branching
points within the epidermis were counted as a single
IENF. Fibers with branching points in the dermis were
counted as each single IENF. The length along the lower
margin of the stratum corneum was defined as epidermal
length and determined using Image J software (version
1.44d; National Institutes of Health, Bethesda, MD, USA).
The density of IENF was expressed as the counted
epidermal fibers divided by the epidermal length (fibers/
cm).Statistic analysis
All data were expressed as mean  standard derivation of
the mean. The means among the vehicle, RTX, and 4MCFigure 1. Differential denervation of peptidergic intraepiderm
neuropathy. Different phenotypes of peptidergic IENFs were demons
gene-related peptide (CGRP) antiserum in (A and B) vehicle and (C an
group, (A) SP(þ) and (B) CGRP(þ) IENFs penetrated into epidermis
than SP(þ) IENFs. On RTXd7, (C) SP(þ) IENFs were completely deple
The graph shows the quantitation of IENF according to Fig. 1AeD. Bgroup were analyzed by nonparametric ManneWhitney
test. A p value < 0.05 was taken to be significant.
Results
Depletion of SP(D) and CGRP(D) IENFs in RTX-
induced neuropathy
In the vehicle group, typical SP(þ) and CGRP(þ) IENFs
emerged from the subepidermal plexuses with varicose
appearances. The number of CGRP(þ) IENFs were more
abundant than SP(þ) IENFs (Fig. 1A and B). On RTXd7, SP(þ)
IENFs were completely depleted (Fig. 1C) and CGRP(þ)
IENFs were significantly reduced (Fig. 1D). The observations
of reduced SP(þ) and CGRP(þ) IENFs were verified by
quantitative comparison (Fig. 1E).al nerve fibers (IENFs) after resiniferatoxin (RTX)-induced
trated by (A and C) anti-substance P (SP) and (B and D) calcitonin
d D) on day 7 (RTXd7) of RTX-induced neuropathy. In the vehicle
from subepidermal plexus. CGRP(þ) IENFs were more abundant
ted and (D) there was partial denervation by CGRP(þ) IENFs. (E)
arZ 50 mm; *statistically significant at p < 0.05.
Figure 2. Effect of 4-methylcatechol (4MC) on the reinnervation of substance P (SP)(þ) intraepidermal nerve fibers (IENFs) in
resiniferatoxin (RTX)-induced neuropathy. SP(þ) IENFs were demonstrated by anti-SP antiserum in RTX (A, C, E) and 4MC (B, D, F)
groups on (A and B) day 35 (RTXd35), (C and D) RTXd56, and (E and F) RTXd84 after RTX-induced neuropathy. There was no
significant reinnervation of SP(þ) IENF in the RTX and 4MC groups. (G) The graph shows the quantitation of SP(þ) IENFs according to
Fig. 2AeF. Bar Z 50 mm; *p < 0.05, **p < 0.01, ***p < 0.001. NS Z no significant difference.
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RTX treatment
To explore the long-term effects of RTX, we quantified the
skin innervation for SP(þ) and CGRP(þ) IENFs on RTXd35,RTXd56 and RTXd84, respectively. There were negligible
SP(þ) IENFs on RTXd35 (1.2  2.6 vs. 26.3  12.6 fibers/cm,
p Z 0.0024), RTXd56 (4.2  4.0 vs. 26.5  5.2 fibers/cm,
p Z 0.0016), and RTXd84 (4.0  1.8 vs. 27.3  7.1 fibers/
cm, pZ 0.0043) (Fig. 2A, C, E and G). 4MC had no effect on
Figure 3. Effect of 4-methylcatechol (4MC) on the reinnervation of calcitonin gene-related peptide (CGRP)(þ) intraepidermal
nerve fibers (IENFs) in resiniferatoxin (RTX)-induced neuropathy. CGRP(þ) IENFs were demonstrated by anti-CGRP antiserum in (A,
C, E) RTX and (B, D, F) 4MC groups on (A and B) day 35 (RTXd35), (C and D) RTXd56, and (E and F) RTXd84 after RTX-induced
neuropathy. (A, C, E) There was gradual reinnervation of CGRP(þ) IENFs from RTXd35 to RTXd84 of the RTX group. (B, D, F)
There was marked reinnervation of CGRP(þ) IENFs on (B) RTXd35, (D) RTXd56 and (F) RTXd84 upon 4MC treatment. (G) The graph
shows the quantitation of CGRP(þ) IENFs according to Fig. 3AeF. Bar Z 50 mm; *p < 0.05, **p < 0.01, ***p < 0.001. NS Z no
significant difference.
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contrast to the absence of SP(þ) IENFs, CGRP(þ) IENFs
were gradually reinnervated from RTXd35 to RTXd84
(Fig. 3A, C, E and G). Interestingly, there was significant
reinnervation of CGRP(þ) IENFs on RTXd35 by 4MC
compared with CGRP(þ) IENFs in the RTX group
(51.3  20.0 vs. 28.8  14.4 fibers/cm, p < 0.012; Fig. 3A
vs. 3B); such reinnervation was complete as compared with
the vehicle group on RTXd56 (66.6  12.4 vs.
70.6  7.2 fibers/cm, p Z 0.39; Fig. 1B vs. D) and RTXd84
(75.1  15.3 vs. 75.2  16.9 fibers/cm, pZ 0.71) (Fig. 3F).
Taken together, 4MC could accelerate the reinnervation of
CGRP(þ) IENFs but it had no effect on SP(þ) IENFs.4MC normalized the thermal analgesia in
RTX-induced neuropathy corresponding with the
skin innervation
The typical thermal analgesia was induced on RTXd7
(22.8  1.9 vs. 10.5  1.6 seconds, p < 0.0001) and per-
sisted through RTXd42 (18.3  2.3 vs. 10.3  0.7 seconds,
p Z 0.016). On RTXd49, thermal latencies became
normalized (14.2  5.2 vs. 9.4  2.2 seconds, p Z 0.40),
until the end of the experimental period on RTXd84
(11.3  3.5 vs. 10.8  1.9 seconds, p Z 0.85). In the 4MC
group, the thermal latency was reduced on RTXd35 as
compared with the RTX group (12.9  1.7 vs. 20.1  4.0
seconds; p Z 0.007) (Fig. 4).
In summary, the patterns of thermal latencies in the 4MC
group correlated to the patterns of CGRP(þ) IENFs’ inner-
vation but not to those of SP(þ) IENFs, indicating thatFigure 4. 4-Methylcatechol (4MC) reduced the duration of
thermal analgesia in resiniferatoxin (RTX)-induced neuropathy.
The thermal latencies were evaluated by hot plate test before
and weekly after RTX-induced neuropathy. There was no
change of thermal latencies in the vehicle group (open
squares). The thermal analgesia was induced on day 7 of RTX-
induced neuropathy (RTXd7) and up to RTXd42 (filled squares).
After the administration of 4MC, the duration of thermal
analgesia was significantly reduced (open circles). *Statistically
significant at p < 0.05 compared with the vehicle group.
**Statistically significant at p < 0.05 compared with the RTX
group.CGRP(þ) IENFs were responsible for the transmission of
thermal nociception.
Discussion
The main findings of this report include the following: (1)
differential depletion of SP(þ) and CGRP(þ) IENF resulted
in reversible reinnervation of CGRP(þ) IENFs but not in
SP(þ) IENFs after RTX treatment. (2) 4MC could promote
the reinnervation of CGRP(þ) IENFs. (3) Finally, these
patterns of CGRP(þ) IENFs were parallel to the course of
thermal analgesia.
RTX induced discrepancy in denervation and
reinnervation of SP(D) and CGRP(D) IENFs
RTX induced the depletion of TRPV1(þ) neurons [2] and skin
denervation [8]. In addition, RTX depleted the small-
diameter nerves in genitourinary system with a different
effect [15]. However, there was no report addressing the
reinnervation of IENFs in terms of different phenotypic
small-diameter nerves in late-stage RTX-induced neurop-
athy. In this report, we have demonstrated that RTX induces
the denervation of SP(þ) and CGRP(þ) IENFs to varying
degrees. These discrepancies in SP(þ) and CGRP(þ) IENFs
corresponded to the differential depletion of SP(þ) and
CGRP(þ) neurons in lumbar DRG whose peripheral terminal
innervated the hind paw skin [2]. This discrepancy in the
depletion of SP(þ) and CGRP(þ) DRG neurons was due to
different ratios of co-localization with TRPV1(þ) DRG
neurons, which were depleted by RTX. CGRP(þ) neurons
account for the relative resistance of CGRP(þ) neurons to
RTX treatment as compared with SP(þ) neurons [16] and
they provide the possibility of reinnervation by CGRP(þ)
IENFs after RTX-induced neuropathy [17], that is, the rein-
nervation in the late phase may result from the survival of
CGRP(þ) neurons that contributed to the reinnervation of
CGRP(þ) IENFs in the late phase. In this report, reversible
CGRP(þ) IENFs in the late phase provided a possible
pathway for thermal nociceptive transmissions.
4MC attenuated the duration of thermal analgesia
and promoted the reinnervation of CGRP(D) IENFs
This report demonstrated that 4MC attenuated the duration
of thermal analgesia and promoted the reinnervation of
CGRP(þ) IENFs in the late phase of RTX-induced neurop-
athy. The densities of CGRP(þ) IENFs reached a nadir on
RTXd7 and then gradually increased from RTXd35 to
RTXd56, corresponding to the course of thermal analgesia.
This report suggests that CGRP(þ) IENFs contributes to the
thermal nociceptive transmission. In addition, we further
demonstrated the effect of 4MC on both attenuating the
duration of thermal analgesia and promoting the reinner-
vation of CGRP(þ) IENFs. 4MC is a stimulator of several
neurotrophins and promotes skin reinnervation [11]. In this
report, we further addressed the effect of 4MC on the
reinnervation of CGRP(þ) IENFs. The effect of 4MC for the
promotion of reinnervation of CGRP(þ) IENFs may be due to
peptidergic DRG neurons and is neurotrophin dependent.
4MC promoted skin reinnervation 411The cascade pathways after 4MC treatment are not clear,
however, and these merit further investigation.
In summary, this report addressed the effect of 4MC on
the promotion of CGRP(þ) IENFs’ innervation and the
recovery of thermosensation disorders. Thefindings raise the
potential to improve peripheral regeneration and peripheral
neuropathy by increasing neurotrophins synthesis [11,18].Acknowledgments
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